Severe hepatic toxicity after administration of infliximab in psoriasis treatment (original) (raw)

Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting

Mar Llamas-velasco

Actas Dermo-Sifiliográficas, 2015

View PDFchevron_right

Serious liver disease induced by infliximab

Carlos Cañas

Clinical Rheumatology, 2006

View PDFchevron_right

Liver Illness and Psoriatic Patients

Alberto Maraolo

BioMed Research International, 2018

View PDFchevron_right

Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis

mariam mansoori

View PDFchevron_right

Stefano Mancini

Internal and emergency …, 2010

View PDFchevron_right

Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages

Sueli Carneiro

Journal of the European Academy of Dermatology and Venereology, 2007

View PDFchevron_right

Liver biopsies from psoriatics related to methotrexate therapy. 1. Findings in 123 consecutive non-methotrexate treated patients

Allan Nyfors

Acta pathologica et microbiologica Scandinavica. Section A, Pathology, 1976

View PDFchevron_right

Infliximab-induced hepatitis: absence of cross-toxicity with etanercept

Gérard Thiéfin, Marie-danièle Diebold

Joint Bone Spine, 2008

View PDFchevron_right

Adverse reactions of biological therapies in patients with psoriasis

ALEXANDRA LIMBAU

Journal of Mind and Medical Sciences, 2017

View PDFchevron_right

Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?

Guruprasad P Aithal

Alimentary Pharmacology and Therapeutics, 2004

View PDFchevron_right

Infliximab single administration followed by acute liver injury

Enzo Ierardi, Maurizio Nacchiero

Inflammatory Bowel Diseases, 2006

View PDFchevron_right

Onset of Liver Damage after a Single??Administration of Infliximab??in??a Patient with Refractory??Ulcerative Colitis

Enzo Ierardi, Maurizio Nacchiero

Clinical Drug Investigation, 2006

View PDFchevron_right

Biomarkers for methotrexate-induced liver injury: Urinary protein profiling of psoriasis patients

Rosalinde Masereeuw

Toxicology Letters, 2013

View PDFchevron_right

The use of ustekinumab in patients with psoriasis and coexisting renal or hepatic dysfunction – a report of two cases

Bartosz Miziołek

Przegla̧d dermatologiczny

View PDFchevron_right

The exacerbation of cutaneous psoriasis induced by anti - TNF therapy - case report

Mădălina Chiriac

Archive of Clinical Cases, 2014

View PDFchevron_right

Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn’s Disease

Yusuf Coşkun

Digestive Diseases and Sciences, 2016

View PDFchevron_right

Occurrence of hepatoxicicty and elevated liver enzymes in a Crohnʼs disease patient treated with infliximab

Bjørn Moum

Inflammatory Bowel Diseases, 2007

View PDFchevron_right

Psoriasis, the liver, and the gastrointestinal tract

Giampiero Girolomoni

Dermatologic Therapy, 2010

View PDFchevron_right

Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy

Hans-Jürgen Gruss

Rheumatology, 2008

View PDFchevron_right

A retrospective review of methotrexate-induced hepatotoxicity among patients with psoriasis in a tertiary dermatology center in Malaysia

Yin Lee

International Journal of Dermatology, 2012

View PDFchevron_right

Risk of incident liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a population-based study

Zelma Chiesa Fuxench

The Journal of investigative dermatology, 2017

View PDFchevron_right

Skin Adverse Reactions Related to TNF Alpha Inhibitors: Classification and Therapeutic Approach in Psoriatic Patients

Klara Martinaskova

2019

View PDFchevron_right

The onset of psoriasis during the treatment of inflammatory bowel diseases with infliximab: should biological therapy be suspended?

Rogerio Saad

Arquivos de Gastroenterologia, 2012

View PDFchevron_right

The reverse of the coin: Methotrexate and liver fibrosis in a group of psoriatic arthritis patients

Roxana Dumitrascu

Romanian Journal of Rheumatology, 2020

View PDFchevron_right

Therapeutic management with biological anti-TNF-α agent in severe psoriasis associated with chronic hepatitis B: A case report

Stefana Bucur

Experimental and Therapeutic Medicine, 2019

View PDFchevron_right

Paradoxical skin reaction with infliximab treatment

Ricardo Barbosa Lima

Medicina (Ribeirao Preto Online), 2018

View PDFchevron_right

Alcohol, psoriasis, liver disease, and anti-psoriasis drugs

Michelangelo Giovanni Vestita

View PDFchevron_right

Etanercept Therapy of Psoriatic Arthritis in a Patient with Liver Cirrhosis

Joachim Dissemond

Acta Dermato-Venereologica, 2005

View PDFchevron_right

Treatment of severe psoriasis with infliximab: report of two cases

Ines Brajac

Acta dermatovenerologica Croatica : ADC, 2009

View PDFchevron_right

Exacerbation of psoriasis vulgaris by sorafenib treatment for hepatocellular carcinoma

Hidenori Okazaki

Clinical Journal of Gastroenterology, 2020

View PDFchevron_right

Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management

Alan Menter

Journal of the American Academy of Dermatology, 2012

View PDFchevron_right

Adverse reactions of biological therapy for psoriasis

Andreea Dimitriu

2015

View PDFchevron_right

Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor Antagonists

Björn Guðbjörnsson

Clinical Gastroenterology and Hepatology, 2015

View PDFchevron_right

Liver biopsies from patients with psoriasis related to photochemotherapy (PUVA): Findings before and after 1 year of therapy in twelve patients

Allan Nyfors

Journal of the American Academy of Dermatology, 1986

View PDFchevron_right

A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents

Francisco Tausk

Annals of the Rheumatic Diseases, 2006

View PDFchevron_right

Severe hepatic toxicity after administration of infliximab in psoriasis treatment (original) (raw)

Related papers